These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18412852)

  • 1. 2C-T-4 intoxication: acute psychosis caused by a designer drug.
    Miyajima M; Matsumoto T; Ito S
    Psychiatry Clin Neurosci; 2008 Apr; 62(2):243. PubMed ID: 18412852
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute psychosis following ingestion of 'Rapture'.
    Austin H; Monasterio E
    Australas Psychiatry; 2004 Dec; 12(4):406-8. PubMed ID: 15715818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2C or not 2C: phenethylamine designer drug review.
    Dean BV; Stellpflug SJ; Burnett AM; Engebretsen KM
    J Med Toxicol; 2013 Jun; 9(2):172-8. PubMed ID: 23494844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Designer drug induced psychosis].
    Fullajtar M; Ferencz C
    Neuropsychopharmacol Hung; 2012 Jun; 14(2):137-40. PubMed ID: 22710853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute psychosis induced by psychotomimetic drug abuse. I. Clinical findings.
    Bowers MB
    Arch Gen Psychiatry; 1972 Oct; 27(4):437-40. PubMed ID: 5072710
    [No Abstract]   [Full Text] [Related]  

  • 6. N,N-Dimethyltryptamine: DMT-induced psychosis.
    Barbic D; Fernandes J; Eberdt C; Chakraborty A
    Am J Emerg Med; 2020 Sep; 38(9):1961.e1-1961.e2. PubMed ID: 32389398
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthetic cannabinoid-induced psychosis: two adolescent cases.
    Oluwabusi OO; Lobach L; Akhtar U; Youngman B; Ambrosini PJ
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):393-5. PubMed ID: 23083027
    [No Abstract]   [Full Text] [Related]  

  • 8. Citalopram-induced hallucinations and delusions in a young adult.
    Capaldi VF; Carr RB
    Gen Hosp Psychiatry; 2010; 32(6):648.e1-3. PubMed ID: 21112465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hawaiian baby rose wood: case report of an argyreia nervosa induced toxic psychosis].
    Göpel C; Maras A; Schmidt MH
    Psychiatr Prax; 2003 May; 30(4):223-4. PubMed ID: 12768530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 25C-NBOMe, a Novel Designer Psychedelic, Induces Neurotoxicity 50 Times More Potent Than Methamphetamine In Vitro.
    Xu P; Qiu Q; Li H; Yan S; Yang M; Naman CB; Wang Y; Zhou W; Shen H; Cui W
    Neurotox Res; 2019 May; 35(4):993-998. PubMed ID: 30806983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of commercial enzyme-linked immunosorbent assays to identify psychedelic phenethylamines.
    Kerrigan S; Mellon MB; Banuelos S; Arndt C
    J Anal Toxicol; 2011 Sep; 35(7):444-51. PubMed ID: 21871153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New designer phenethylamines 2C-C and 2C-P have abuse potential and induce neurotoxicity in rodents.
    Kim YJ; Ma SX; Hur KH; Lee Y; Ko YH; Lee BR; Kim SK; Sung SJ; Kim KM; Kim HC; Lee SY; Jang CG
    Arch Toxicol; 2021 Apr; 95(4):1413-1429. PubMed ID: 33515270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone addition and psychotic exacerbation.
    Terao T; Kojima H
    J Neuropsychiatry Clin Neurosci; 2001; 13(1):114-5. PubMed ID: 11207341
    [No Abstract]   [Full Text] [Related]  

  • 14. Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia.
    Darke S; Duflou J; Peacock A; Farrell M; Lappin J
    Drug Alcohol Depend; 2019 Nov; 204():107556. PubMed ID: 31546120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry.
    Habrdova V; Peters FT; Theobald DS; Maurer HH
    J Mass Spectrom; 2005 Jun; 40(6):785-95. PubMed ID: 15827969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychotic disorders related with chronic use of mephedrone. Case report].
    Urban M; Rudecki T; Wróblewski D; Rabe-Jabłońska J
    Psychiatr Pol; 2011; 45(3):431-7. PubMed ID: 22232972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-MeO-DALT; a novel designer drug on the market causing acute delirium and rhabdomyolysis.
    Kalasho A; Vibe Nielsen S
    Acta Anaesthesiol Scand; 2016 Oct; 60(9):1332-6. PubMed ID: 27453155
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent seizures and serotonin syndrome following "2C-I" ingestion.
    Bosak A; LoVecchio F; Levine M
    J Med Toxicol; 2013 Jun; 9(2):196-8. PubMed ID: 23378129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drugs of abuse update: Foxy Methoxy.
    Muller AA
    J Emerg Nurs; 2004 Oct; 30(5):507-8. PubMed ID: 15452541
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthetic cannabinoids: A review of the clinical implications of a new drug of choice.
    Freund SA; Banning AS
    JAAPA; 2017 Nov; 30(11):1-4. PubMed ID: 29064946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.